Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies

Yuanyue Li,1,* Tao Yu,1,* Huang Yan,2 Duanduan Li,2 Tang Yu,2 Tao Yuan,1 Abdul Rahaman,3 Shahid Ali,3 Farhat Abbas,2 Ziqin Dian,4 Xiaomei Wu,1 Zulqarnain Baloch5 1Department of Gynaecology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan, People’s Republic...

Full description

Bibliographic Details
Main Authors: Li Y, Yu T, Yan H, Li D, Yuan T, Rahaman A, Ali S, Abbas F, Dian Z, Wu X, Baloch Z
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/vaginal-microbiota-and-hpv-infection-novel-mechanistic-insights-and-th-peer-reviewed-article-IDR
id doaj-d31f9662493f4ae9828ce0abae37be9b
record_format Article
spelling doaj-d31f9662493f4ae9828ce0abae37be9b2020-11-25T02:26:29ZengDove Medical PressInfection and Drug Resistance1178-69732020-04-01Volume 131213122053457Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic StrategiesLi YYu TYan HLi DYu TYuan TRahaman AAli SAbbas FDian ZWu XBaloch ZYuanyue Li,1,* Tao Yu,1,* Huang Yan,2 Duanduan Li,2 Tang Yu,2 Tao Yuan,1 Abdul Rahaman,3 Shahid Ali,3 Farhat Abbas,2 Ziqin Dian,4 Xiaomei Wu,1 Zulqarnain Baloch5 1Department of Gynaecology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan, People’s Republic of China; 2South China Agricultural University, Guangzhou 510642, People’s Republic of China; 3School of Food Science and Engineering, South China University of Technology, Guangzhou, People’s Republic of China; 4Department of Clinical Laboratory, The First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, People’s Republic of China; 5Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zulqarnain BalochBiomedical Research Center, Northwest Minzu University, Lanzhou 730030, People’s Republic of ChinaTel +86 18344564625Email znbalooch@yahoo.comAbstract: Cervical cancer is a global public health concern. The complex interaction of genetic and environmental factors is critical for the progress of cervical cancer. Growing evidence suggests that microbes, human papillomavirus (HPV), and the immune system interact closely with each other to govern homeostasis of the vaginal environment and the health of the lower genital tract of females. Certain vaginal microbial strains may play either a protective or a pathogenic role in carcinogenesis of the cervix after HPV persistent infection. Probiotics can therefore present a putative therapeutic approach for cervical cancer. However, work in this field remains limited. Recent technological developments have allowed us to identify microbes and their products using culture-independent molecular detection techniques. In this review, we discuss the composition of the vaginal bacterial community, its commensal flora and the protective impact this has on the health of the female genital tract. This review will also describe critical immune factors in lower genital tract health and summarize the role of the vaginal microbiota in cervical carcinogenesis. Knowledge in this field has provided researchers with the clues and tools to propose the use of probiotics as a potential line of treatment for cervical cancer and has provided valuable insights into host–pathogen interaction dynamics within the female genital tract.Keywords: vaginal microbiota, human papillomavirus, cervical cancer, immune system, probiotic therapyhttps://www.dovepress.com/vaginal-microbiota-and-hpv-infection-novel-mechanistic-insights-and-th-peer-reviewed-article-IDRvaginal microbiotahuman papillomaviruscervical cancerimmune systemprobiotic therapy
collection DOAJ
language English
format Article
sources DOAJ
author Li Y
Yu T
Yan H
Li D
Yu T
Yuan T
Rahaman A
Ali S
Abbas F
Dian Z
Wu X
Baloch Z
spellingShingle Li Y
Yu T
Yan H
Li D
Yu T
Yuan T
Rahaman A
Ali S
Abbas F
Dian Z
Wu X
Baloch Z
Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
Infection and Drug Resistance
vaginal microbiota
human papillomavirus
cervical cancer
immune system
probiotic therapy
author_facet Li Y
Yu T
Yan H
Li D
Yu T
Yuan T
Rahaman A
Ali S
Abbas F
Dian Z
Wu X
Baloch Z
author_sort Li Y
title Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
title_short Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
title_full Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
title_fullStr Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
title_full_unstemmed Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies
title_sort vaginal microbiota and hpv infection: novel mechanistic insights and therapeutic strategies
publisher Dove Medical Press
series Infection and Drug Resistance
issn 1178-6973
publishDate 2020-04-01
description Yuanyue Li,1,* Tao Yu,1,* Huang Yan,2 Duanduan Li,2 Tang Yu,2 Tao Yuan,1 Abdul Rahaman,3 Shahid Ali,3 Farhat Abbas,2 Ziqin Dian,4 Xiaomei Wu,1 Zulqarnain Baloch5 1Department of Gynaecology, The First People’s Hospital of Yunnan Province, Kunming 650032, Yunnan, People’s Republic of China; 2South China Agricultural University, Guangzhou 510642, People’s Republic of China; 3School of Food Science and Engineering, South China University of Technology, Guangzhou, People’s Republic of China; 4Department of Clinical Laboratory, The First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, People’s Republic of China; 5Biomedical Research Center, Northwest Minzu University, Lanzhou 730030, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zulqarnain BalochBiomedical Research Center, Northwest Minzu University, Lanzhou 730030, People’s Republic of ChinaTel +86 18344564625Email znbalooch@yahoo.comAbstract: Cervical cancer is a global public health concern. The complex interaction of genetic and environmental factors is critical for the progress of cervical cancer. Growing evidence suggests that microbes, human papillomavirus (HPV), and the immune system interact closely with each other to govern homeostasis of the vaginal environment and the health of the lower genital tract of females. Certain vaginal microbial strains may play either a protective or a pathogenic role in carcinogenesis of the cervix after HPV persistent infection. Probiotics can therefore present a putative therapeutic approach for cervical cancer. However, work in this field remains limited. Recent technological developments have allowed us to identify microbes and their products using culture-independent molecular detection techniques. In this review, we discuss the composition of the vaginal bacterial community, its commensal flora and the protective impact this has on the health of the female genital tract. This review will also describe critical immune factors in lower genital tract health and summarize the role of the vaginal microbiota in cervical carcinogenesis. Knowledge in this field has provided researchers with the clues and tools to propose the use of probiotics as a potential line of treatment for cervical cancer and has provided valuable insights into host–pathogen interaction dynamics within the female genital tract.Keywords: vaginal microbiota, human papillomavirus, cervical cancer, immune system, probiotic therapy
topic vaginal microbiota
human papillomavirus
cervical cancer
immune system
probiotic therapy
url https://www.dovepress.com/vaginal-microbiota-and-hpv-infection-novel-mechanistic-insights-and-th-peer-reviewed-article-IDR
work_keys_str_mv AT liy vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT yut vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT yanh vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT lid vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT yut vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT yuant vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT rahamana vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT alis vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT abbasf vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT dianz vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT wux vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
AT balochz vaginalmicrobiotaandhpvinfectionnovelmechanisticinsightsandtherapeuticstrategies
_version_ 1724846708757626880